Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder

Jorge Perez, Daniela Tardito, Silvia Mori, Giorgio Racagni, Enrico Smeraldi, Raffaella Zanardi

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Abnormalities in the cyclic adenosine monophosphate (cAMP)- dependent phosphorylation system have been recently reported in patients with bipolar disorder. We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects. Methods: Platelets were collected from 112 drug-free patients with bipolar disorder (52 euthymic, 29 depressed, and 31 manic) and 62 healthy subjects. The levels of cAMP-dependent protein kinase and Rap1 were assessed by Western blot analysis, immunostaining, and computer-assisted imaging. Results: The immunolabeling of the catalytic subunit of cAMP-dependent protein kinase was significantly different among groups (P <.001), with higher values in untreated depressed and manic patients with bipolar disorder compared with untreated euthymic patients with bipolar disorder and healthy subjects. No significant differences were found in the immunolabeling of the regulatory subunits (type I and type II) of cAMP-dependent protein kinase. The immunolabeling of Rap1 was significantly higher (P <.001) in untreated euthymic, depressed, and manic patients than in healthy persons. Conclusions: Levels of Rap1 and the catalytic subunit of cAMP-dependent protein kinase are altered in the platelets of bipolar patients. These findings may provide clues toward understanding the involvement of cAMP signaling in the pathogenesis of bipolar disorder.

Original languageEnglish
Pages (from-to)248-253
Number of pages6
JournalArchives of General Psychiatry
Volume56
Issue number3
Publication statusPublished - Mar 1999

Fingerprint

Bipolar Disorder
Cyclic AMP
Cyclic AMP-Dependent Protein Kinases
Blood Platelets
Catalytic Domain
Healthy Volunteers
Protein
Western Blotting
Phosphorylation
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Perez, J., Tardito, D., Mori, S., Racagni, G., Smeraldi, E., & Zanardi, R. (1999). Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Archives of General Psychiatry, 56(3), 248-253.

Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. / Perez, Jorge; Tardito, Daniela; Mori, Silvia; Racagni, Giorgio; Smeraldi, Enrico; Zanardi, Raffaella.

In: Archives of General Psychiatry, Vol. 56, No. 3, 03.1999, p. 248-253.

Research output: Contribution to journalArticle

Perez, J, Tardito, D, Mori, S, Racagni, G, Smeraldi, E & Zanardi, R 1999, 'Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder', Archives of General Psychiatry, vol. 56, no. 3, pp. 248-253.
Perez, Jorge ; Tardito, Daniela ; Mori, Silvia ; Racagni, Giorgio ; Smeraldi, Enrico ; Zanardi, Raffaella. / Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. In: Archives of General Psychiatry. 1999 ; Vol. 56, No. 3. pp. 248-253.
@article{b6c067f6207243bcb81b9410ae8633e9,
title = "Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder",
abstract = "Background: Abnormalities in the cyclic adenosine monophosphate (cAMP)- dependent phosphorylation system have been recently reported in patients with bipolar disorder. We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects. Methods: Platelets were collected from 112 drug-free patients with bipolar disorder (52 euthymic, 29 depressed, and 31 manic) and 62 healthy subjects. The levels of cAMP-dependent protein kinase and Rap1 were assessed by Western blot analysis, immunostaining, and computer-assisted imaging. Results: The immunolabeling of the catalytic subunit of cAMP-dependent protein kinase was significantly different among groups (P <.001), with higher values in untreated depressed and manic patients with bipolar disorder compared with untreated euthymic patients with bipolar disorder and healthy subjects. No significant differences were found in the immunolabeling of the regulatory subunits (type I and type II) of cAMP-dependent protein kinase. The immunolabeling of Rap1 was significantly higher (P <.001) in untreated euthymic, depressed, and manic patients than in healthy persons. Conclusions: Levels of Rap1 and the catalytic subunit of cAMP-dependent protein kinase are altered in the platelets of bipolar patients. These findings may provide clues toward understanding the involvement of cAMP signaling in the pathogenesis of bipolar disorder.",
author = "Jorge Perez and Daniela Tardito and Silvia Mori and Giorgio Racagni and Enrico Smeraldi and Raffaella Zanardi",
year = "1999",
month = "3",
language = "English",
volume = "56",
pages = "248--253",
journal = "Archives of General Psychiatry",
issn = "0003-990X",
publisher = "American Medical Association",
number = "3",

}

TY - JOUR

T1 - Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder

AU - Perez, Jorge

AU - Tardito, Daniela

AU - Mori, Silvia

AU - Racagni, Giorgio

AU - Smeraldi, Enrico

AU - Zanardi, Raffaella

PY - 1999/3

Y1 - 1999/3

N2 - Background: Abnormalities in the cyclic adenosine monophosphate (cAMP)- dependent phosphorylation system have been recently reported in patients with bipolar disorder. We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects. Methods: Platelets were collected from 112 drug-free patients with bipolar disorder (52 euthymic, 29 depressed, and 31 manic) and 62 healthy subjects. The levels of cAMP-dependent protein kinase and Rap1 were assessed by Western blot analysis, immunostaining, and computer-assisted imaging. Results: The immunolabeling of the catalytic subunit of cAMP-dependent protein kinase was significantly different among groups (P <.001), with higher values in untreated depressed and manic patients with bipolar disorder compared with untreated euthymic patients with bipolar disorder and healthy subjects. No significant differences were found in the immunolabeling of the regulatory subunits (type I and type II) of cAMP-dependent protein kinase. The immunolabeling of Rap1 was significantly higher (P <.001) in untreated euthymic, depressed, and manic patients than in healthy persons. Conclusions: Levels of Rap1 and the catalytic subunit of cAMP-dependent protein kinase are altered in the platelets of bipolar patients. These findings may provide clues toward understanding the involvement of cAMP signaling in the pathogenesis of bipolar disorder.

AB - Background: Abnormalities in the cyclic adenosine monophosphate (cAMP)- dependent phosphorylation system have been recently reported in patients with bipolar disorder. We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects. Methods: Platelets were collected from 112 drug-free patients with bipolar disorder (52 euthymic, 29 depressed, and 31 manic) and 62 healthy subjects. The levels of cAMP-dependent protein kinase and Rap1 were assessed by Western blot analysis, immunostaining, and computer-assisted imaging. Results: The immunolabeling of the catalytic subunit of cAMP-dependent protein kinase was significantly different among groups (P <.001), with higher values in untreated depressed and manic patients with bipolar disorder compared with untreated euthymic patients with bipolar disorder and healthy subjects. No significant differences were found in the immunolabeling of the regulatory subunits (type I and type II) of cAMP-dependent protein kinase. The immunolabeling of Rap1 was significantly higher (P <.001) in untreated euthymic, depressed, and manic patients than in healthy persons. Conclusions: Levels of Rap1 and the catalytic subunit of cAMP-dependent protein kinase are altered in the platelets of bipolar patients. These findings may provide clues toward understanding the involvement of cAMP signaling in the pathogenesis of bipolar disorder.

UR - http://www.scopus.com/inward/record.url?scp=0033019227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033019227&partnerID=8YFLogxK

M3 - Article

VL - 56

SP - 248

EP - 253

JO - Archives of General Psychiatry

JF - Archives of General Psychiatry

SN - 0003-990X

IS - 3

ER -